These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25355835)

  • 21. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
    Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
    Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.
    Tiamkao S; Jitpimolmard J; Sawanyawisuth K; Jitpimolmard S
    Int J Clin Pharm; 2013 Aug; 35(4):608-12. PubMed ID: 23649893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population.
    Ihtisham K; Ramanujam B; Srivastava S; Mehra NK; Kaur G; Khanna N; Jain S; Kumar S; Kaul B; Samudrala R; Tripathi M
    Seizure; 2019 Mar; 66():99-103. PubMed ID: 30826555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
    Chang CC; Ng CC; Too CL; Choon SE; Lee CK; Chung WH; Hussein SH; Lim KS; Murad S
    Pharmacogenomics J; 2017 Mar; 17(2):170-173. PubMed ID: 26927288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.
    Rzany B; Correia O; Kelly JP; Naldi L; Auquier A; Stern R
    Lancet; 1999 Jun; 353(9171):2190-4. PubMed ID: 10392983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
    Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
    Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
    Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
    Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions.
    Lin YT; Chang YC; Hui RC; Yang CH; Ho HC; Hung SI; Chung WH
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):356-64. PubMed ID: 22211830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs.
    Ordoñez L; Salgueiro E; Jimeno FJ; Manso G
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2732-7. PubMed ID: 26221907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
    Wu XT; Hu FY; An DM; Yan B; Jiang X; Kwan P; Stefan H; Zhou D
    Epilepsy Behav; 2010 Nov; 19(3):405-8. PubMed ID: 20833111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions.
    Locharernkul C; Shotelersuk V; Hirankarn N
    J Clin Neurosci; 2011 Oct; 18(10):1289-94. PubMed ID: 21802305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children.
    Manuyakorn W; Siripool K; Kamchaisatian W; Pakakasama S; Visudtibhan A; Vilaiyuk S; Rujirawat T; Benjaponpitak S
    Pediatr Allergy Immunol; 2013 May; 24(3):299-303. PubMed ID: 23551241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Making Rash Decisions in Epilepsy: Evaluating Hypersensitivity Reactions to Anti-seizure Medications.
    Bermeo-Ovalle A
    Epilepsy Curr; 2019; 19(2):96-98. PubMed ID: 30955419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic predisposition of life-threatening antiepileptic-induced skin reactions.
    Chung WH; Hung SI; Chen YT
    Expert Opin Drug Saf; 2010 Jan; 9(1):15-21. PubMed ID: 20001755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.
    Dong D; Sung C; Finkelstein EA
    Neurology; 2012 Sep; 79(12):1259-67. PubMed ID: 22955130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the HLA-B*1502 gene and mild maculopapular exanthema induced by antiepileptic drugs in Northwest China.
    Shafeng N; Han DF; Ma YF; Abudusalamu R; Ayitimuhan B
    BMC Neurol; 2021 Sep; 21(1):340. PubMed ID: 34488672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
    Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.
    Frey N; Bodmer M; Bircher A; Rüegg S; Jick SS; Meier CR; Spoendlin J
    Epilepsia; 2017 Dec; 58(12):2178-2185. PubMed ID: 29027197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.